Area of research
Psychiatry and Mental health · Cellular and Molecular Neuroscience
Research interest
Research interests include Schizophrenia research and treatment, Neurotransmitter Receptor Influence on Behavior, Bipolar Disorder and Treatment, and Treatment of Major Depression.
Utility of Antidepressant Randomized Controlled Trials for Regular Treatment.
Birds may represent a useful animal model for studying human mental disorders.
Major Limitations of Randomized Controlled Trials Assessing Antidepressant Efficacy.
Comment on Chaparro-Solano et al.: "Critical evaluation of the current landscape of pharmacogenomics in Parkinson's disease - What is missing? A systematic review." Parkinsonism Relat Disord. 2025 Jan;130:107206.
The putative role of the habenula in animal migration.
Microsampling Techniques Suitable for Therapeutic Drug Monitoring of Antipsychotics.
Putative role of immune reactions in the mechanism of tardive dyskinesia.
Cytokine level in patients with mood disorder, alcohol use disorder and their comorbidity.
Polymorphisms in the adrenergic neurotransmission pathway impact antidepressant response in depressed patients
Comment on Martino et al. "Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations".
The Mechanism of Akathisia - Comments on Wu et al. Eur Neuropsychopharmacol 2023;72:40-49.
Circuits regulating pleasure and happiness - focus on potential biomarkers for circuitry including the habenuloid complex.
Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design.
Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome.
The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia.
Population pharmacokinetic model and limited sampling strategy for clozapine using plasma and dried blood spot samples.
Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia.
Neurobiological mechanisms associated with antipsychotic drug-induced dystonia.
Study of Early Onset Schizophrenia: Associations of <i>GRIN2A</i> and <i>GRIN2B</i> Polymorphisms.
Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics.
Genetic Polymorphisms of <i>5-HT</i> Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia.
Search for Possible Associations of <i>FTO</i> Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients.
Beta-Endorphin and Oxytocin in Patients with Alcohol Use Disorder and Comorbid Depression.
Comparative Characteristics of the Metabolic Syndrome Prevalence in Patients With Schizophrenia in Three Western Siberia Psychiatric Hospitals.
Clinical Evaluation of Different Treatment Strategies for Motor Recovery in Poststroke Rehabilitation during the First 90 Days.
Putative role of vitamin D in the mechanism of alcoholism and other addictions - a hypothesis.
Association of <i>PIP4K2A</i> Polymorphisms with Alcohol Use Disorder.
Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action.
A New Paradigm to Indicate Antidepressant Treatments.
Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients.